1Insurance coverage for the expensive drug Keytruda will expand.
2A government committee approved coverage for various cancer types.
3Cancer patients' financial burden is expected to drop significantly.
📖 Easy Explanation
🔍 Background
Keytruda is a highly effective but expensive cancer drug. Without insurance, patients had to pay tens of thousands of dollars annually, causing significant financial hardship.
📌 Key Points
A specialized committee has approved expanding coverage. Now, patients with various cancers, not just lung cancer, can access affordable treatment with government support.
💡 Why It Matters
Drug costs per session will drop significantly thanks to health insurance. This is great news for elderly patients and families struggling with medical expenses.
🔮 What's Next
The government and the pharmaceutical company will finalize the drug price. Once settled, the official date for insurance benefits will be announced.
📚 Glossary
약평위 (Yakpyeongwi)The Drug Benefit Appraisal Committee that reviews the value and price of drugs for health insurance coverage.
키트루다 (Keytruda)A high-cost 3rd-generation immunotherapy drug that boosts the immune system to attack cancer cells.
급여 확대 (Geubyeo hwakdae)Expanding the scope of patients or types of diseases eligible for health insurance benefits.